McKesson Corporation McKesson Corporation

McKesson Corporation

MCK

Rangering i aksjer #187
McKesson Corporation is a prominent global provider of healthcare services,... McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Aksjekurs
$1,029.14
Markedsverdi
$119.99B
Endring (1 dag)
1.73%
Endring (1 år)
30.63%
Land
US
Handel McKesson Corporation (MCK)

Kategori

Healthcare
Antall utestående aksjer for McKesson Corporation (MCK)
Antall utestående aksjer per June 2026: 118.70M
Ifølge McKesson Corporation sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 118.70M. Ved slutten av March 2024 hadde selskapet 133.20M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for McKesson Corporation (MCK) fra 2000 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 118.70M -6.83%
2025 127.40M -4.35%
2024 133.20M -5.60%
2023 141.10M -7.35%
2022 152.30M -5.17%
2021 160.60M -11.27%
2020 181.00M -7.79%
2019 196.30M -5.63%
2018 208.00M -5.88%
2017 221.00M -3.91%
2016 230.00M -0.86%
2015 232.00M 1.31%
2014 229.00M -2.55%
2013 235.00M -4.47%
2012 246.00M -4.65%
2011 258.00M -4.09%
2010 269.00M -2.18%
2009 275.00M -5.50%
2008 291.00M -2.35%
2007 298.00M -2.61%
2006 306.00M 4.08%
2005 294.00M 1.38%
2004 290.00M 0.24%
2003 289.30M 1.44%
2002 285.20M 0.74%
2001 283.10M 0.64%
2000 281.30M 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
- -
US
236.00M 98.82%
US
- -
US
11.50B 9,590.60%
AU
113.45M -4.42%
US